| Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei, H Wang, J Xie, ... Cell metabolism 31 (6), 1068-1077. e3, 2020 | 1848 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1330 | 2020 |
| In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 XJ Zhang, JJ Qin, X Cheng, L Shen, YC Zhao, Y Yuan, F Lei, MM Chen, ... Cell metabolism 32 (2), 176-187. e4, 2020 | 509 | 2020 |
| Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 470 | 2020 |
| Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 182 | 2020 |
| Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 158 | 2020 |
| The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19 J Cai, H Li, C Zhang, Z Chen, H Liu, F Lei, JJ Qin, YM Liu, F Zhou, X Song, ... Cell metabolism 33 (2), 258-269. e3, 2021 | 119 | 2021 |
| Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease W Wang, M Hu, H Liu, X Zhang, H Li, F Zhou, YM Liu, F Lei, JJ Qin, ... Cell metabolism 33 (10), 1943-1956. e2, 2021 | 99 | 2021 |
| Kidney function indicators predict adverse outcomes of COVID-19 YM Liu, J Xie, MM Chen, X Zhang, X Cheng, H Li, F Zhou, JJ Qin, F Lei, ... Med 2 (1), 38-48. e2, 2021 | 83 | 2021 |
| Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality F Zhou, YM Liu, J Xie, H Li, F Lei, H Yang, JJ Qin, J Cai, XJ Zhang, B Wu, ... Hypertension 76 (2), e15-e17, 2020 | 73 | 2020 |
| Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data J Zou, T Sun, X Song, YM Liu, F Lei, MM Chen, Z Chen, P Zhang, YX Ji, ... Respiratory research 23 (1), 90, 2022 | 45 | 2022 |
| No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19 JH Zhou, B Wu, WX Wang, F Lei, X Cheng, JJ Qin, JJ Cai, XJ Zhang, ... World journal of clinical cases 8 (22), 5576, 2020 | 34 | 2020 |
| High remnant cholesterol level potentiates the development of hypertension MM Chen, X Huang, C Xu, XH Song, YM Liu, D Yao, H Lu, G Wang, ... Frontiers in endocrinology 13, 830347, 2022 | 30 | 2022 |
| The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China F Lei, JJ Qin, X Song, YM Liu, MM Chen, T Sun, X Huang, KQ Deng, ... Frontiers in Endocrinology 13, 1007171, 2022 | 26 | 2022 |
| Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients H Liu, J Chen, Q Yang, F Lei, C Zhang, JJ Qin, Z Chen, L Zhu, X Song, ... Med 2 (4), 435-447. e4, 2021 | 26 | 2021 |
| A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease C Yang, Q He, Z Chen, JJ Qin, F Lei, YM Liu, W Liu, MM Chen, T Sun, ... Frontiers in Endocrinology 13, 821689, 2022 | 23 | 2022 |
| Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy Z Chen, ZX Jin, J Cai, R Li, KQ Deng, YX Ji, F Lei, HP Li, Z Lu, H Li Journal of Molecular Medicine 100 (12), 1721-1739, 2022 | 19 | 2022 |
| Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease KQ Deng, X Huang, F Lei, XJ Zhang, P Zhang, ZG She, J Cai, YX Ji, H Li American Journal of Physiology-Cell Physiology, 2022 | 19 | 2022 |
| Heavy disease burden of high systolic blood pressure during 1990-2019: highlighting regional, sex, and age specific strategies in blood pressure control MM Chen, X Zhang, YM Liu, Z Chen, H Li, F Lei, JJ Qin, Y Ji, P Zhang, ... Frontiers in Cardiovascular Medicine 8, 754778, 2021 | 19 | 2021 |
| Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: Results from the Global Burden of … W Liu, C Yang, Z Chen, F Lei, JJ Qin, H Liu, YX Ji, P Zhang, J Cai, YM Liu, ... Atherosclerosis 347, 17-27, 2022 | 16 | 2022 |
